VIVEVE MED INC
VIVE
VIVE was delisted on the 18th of January, 2023.
21 hedge funds and large institutions have $74.3M invested in VIVEVE MED INC in 2017 Q1 according to their latest regulatory filings, with 11 funds opening new positions, 7 increasing their positions, 1 reducing their positions, and 2 closing their positions.
61,719% more capital inflows, than outflows
Capital inflows: $29.9M | Capital outflows: $48.3K
600% more repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 1
450% more first-time investments, than exits
New positions opened: 11 | Existing positions closed: 2
62% more funds holding
Funds holding: 13 → 21 (+8)
11.71% more ownership
Funds ownership: 52.88% → 64.6% (+12%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SCM
Stonepine Capital Management
Bend,
Oregon
|
+$6.08M |
| 2 |
ACP
Acuta Capital Partners
Redwood City,
California
|
+$5.55M |
| 3 |
Perceptive Advisors
New York
|
+$4.57M |
| 4 |
Avoro Capital Advisors
New York
|
+$4.33M |
| 5 |
HighTower Advisors
Chicago,
Illinois
|
+$1.7M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Goldman Sachs
New York
|
-$24.3K |
| 2 |
UBS Group
Zurich,
Switzerland
|
-$16K |
| 3 |
Parallel Advisors
San Francisco,
California
|
-$6K |
| 4 |
FCB
First Command Bank
Fort Worth,
Texas
|
-$1K |
| 5 |
FCFS
First Command Financial Services
Fort Worth,
Texas
|
-$1K |
VIVE Hedge Fund Activity: Q1 2017 in Review
21 of the 4,035 institutional investors tracked by Wall St. Rank reported a position in VIVEVE MED INC (VIVE) for Q1 2017, worth a combined $74.3M — up 156% from $29.1M a quarter earlier.
Buyers outnumbered sellers: 11 funds opened new VIVE positions and 2 closed out — a net gain of 9 holders — while 7 added to existing stakes and 1 trimmed.
The largest buyer was Stonepine Capital Management, adding an estimated $6.08M. The largest seller was Goldman Sachs, cutting an estimated $24.3K.
- 21 institutional investors held VIVEVE MED INC (VIVE) as of Q1 2017, up from 13 in Q4 2016.
- Funds reported $74.3M of VIVEVE MED INC stock for Q1 2017, up 156% quarter-over-quarter.
- 11 funds opened new VIVEVE MED INC positions in Q1 2017 and 2 closed out, a net change of +9 holders.
- The largest VIVEVE MED INC buyer in Q1 2017 was Stonepine Capital Management, an estimated $6.08M added.
- The largest VIVEVE MED INC seller in Q1 2017 was Goldman Sachs, an estimated $24.3K sold.
Based on aggregated 13F filings for Q1 2017.